vs

Side-by-side financial comparison of Cellebrite DI Ltd. (CLBT) and KADANT INC (KAI). Click either name above to swap in a different company.

Cellebrite DI Ltd. is the larger business by last-quarter revenue ($292.2M vs $271.6M, roughly 1.1× KADANT INC). KADANT INC runs the higher net margin — 10.2% vs -103.5%, a 113.7% gap on every dollar of revenue. Cellebrite DI Ltd. produced more free cash flow last quarter ($60.8M vs $44.1M). Over the past eight quarters, Cellebrite DI Ltd.'s revenue compounded faster (72.8% CAGR vs 6.7%).

Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.

Kadant Inc. is a company that was established in 1991, as a partly privately owned subsidiary of Thermo Electron, and partly publicly traded company, and was fully spun out and renamed Kadant in 2001. The company supports papermaking, paper recycling, wood processing, material handling, and other processing industries. Kadant is a multi-national corporation with operations in Asia, Europe, North America, and South America.

CLBT vs KAI — Head-to-Head

Bigger by revenue
CLBT
CLBT
1.1× larger
CLBT
$292.2M
$271.6M
KAI
Higher net margin
KAI
KAI
113.7% more per $
KAI
10.2%
-103.5%
CLBT
More free cash flow
CLBT
CLBT
$16.8M more FCF
CLBT
$60.8M
$44.1M
KAI
Faster 2-yr revenue CAGR
CLBT
CLBT
Annualised
CLBT
72.8%
6.7%
KAI

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
CLBT
CLBT
KAI
KAI
Revenue
$292.2M
$271.6M
Net Profit
$-302.3M
$27.7M
Gross Margin
84.6%
45.2%
Operating Margin
14.1%
15.7%
Net Margin
-103.5%
10.2%
Revenue YoY
-0.0%
Net Profit YoY
-12.2%
EPS (diluted)
$-1.50
$2.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLBT
CLBT
KAI
KAI
Q3 25
$292.2M
$271.6M
Q2 25
$220.8M
$255.3M
Q1 25
$89.6M
$239.2M
Q4 24
$258.0M
Q3 24
$232.1M
$271.6M
Q2 24
$185.3M
$274.8M
Q1 24
$71.2M
$249.0M
Q4 23
$238.7M
Net Profit
CLBT
CLBT
KAI
KAI
Q3 25
$-302.3M
$27.7M
Q2 25
$36.9M
$26.2M
Q1 25
$-71.4M
$24.1M
Q4 24
$24.0M
Q3 24
$31.6M
Q2 24
$-95.2M
$31.3M
Q1 24
$-40.6M
$24.7M
Q4 23
$27.4M
Gross Margin
CLBT
CLBT
KAI
KAI
Q3 25
84.6%
45.2%
Q2 25
84.1%
45.9%
Q1 25
85.2%
46.1%
Q4 24
43.4%
Q3 24
83.5%
44.7%
Q2 24
84.1%
44.4%
Q1 24
82.6%
44.6%
Q4 23
42.7%
Operating Margin
CLBT
CLBT
KAI
KAI
Q3 25
14.1%
15.7%
Q2 25
12.1%
15.4%
Q1 25
10.3%
14.9%
Q4 24
14.3%
Q3 24
7.9%
18.0%
Q2 24
11.7%
17.6%
Q1 24
0.2%
14.8%
Q4 23
16.3%
Net Margin
CLBT
CLBT
KAI
KAI
Q3 25
-103.5%
10.2%
Q2 25
16.7%
10.2%
Q1 25
-79.7%
10.1%
Q4 24
9.3%
Q3 24
11.6%
Q2 24
-51.4%
11.4%
Q1 24
-57.0%
9.9%
Q4 23
11.5%
EPS (diluted)
CLBT
CLBT
KAI
KAI
Q3 25
$-1.50
$2.35
Q2 25
$0.15
$2.22
Q1 25
$-0.36
$2.04
Q4 24
$2.04
Q3 24
$-0.35
$2.68
Q2 24
$-0.48
$2.66
Q1 24
$-0.21
$2.10
Q4 23
$2.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLBT
CLBT
KAI
KAI
Cash + ST InvestmentsLiquidity on hand
$191.7M
$124.5M
Total DebtLower is stronger
$254.6M
Stockholders' EquityBook value
$336.0M
$949.8M
Total Assets
$690.6M
$1.5B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLBT
CLBT
KAI
KAI
Q3 25
$191.7M
$124.5M
Q2 25
$326.1M
$95.3M
Q1 25
$191.7M
$91.7M
Q4 24
$94.7M
Q3 24
$189.5M
$88.4M
Q2 24
$178.6M
$73.8M
Q1 24
$189.5M
$81.4M
Q4 23
$103.8M
Total Debt
CLBT
CLBT
KAI
KAI
Q3 25
$254.6M
Q2 25
$245.7M
Q1 25
$273.5M
Q4 24
$285.2M
Q3 24
$323.2M
Q2 24
$342.0M
Q1 24
$306.8M
Q4 23
$107.7M
Stockholders' Equity
CLBT
CLBT
KAI
KAI
Q3 25
$336.0M
$949.8M
Q2 25
$408.4M
$926.0M
Q1 25
$336.0M
$876.0M
Q4 24
$847.1M
Q3 24
$34.2M
$851.7M
Q2 24
$-40.2M
$807.7M
Q1 24
$34.2M
$782.7M
Q4 23
$773.7M
Total Assets
CLBT
CLBT
KAI
KAI
Q3 25
$690.6M
$1.5B
Q2 25
$787.4M
$1.5B
Q1 25
$690.6M
$1.4B
Q4 24
$1.4B
Q3 24
$532.9M
$1.5B
Q2 24
$556.6M
$1.5B
Q1 24
$532.9M
$1.4B
Q4 23
$1.2B
Debt / Equity
CLBT
CLBT
KAI
KAI
Q3 25
0.27×
Q2 25
0.27×
Q1 25
0.31×
Q4 24
0.34×
Q3 24
0.38×
Q2 24
0.42×
Q1 24
0.39×
Q4 23
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLBT
CLBT
KAI
KAI
Operating Cash FlowLast quarter
$66.2M
$47.3M
Free Cash FlowOCF − Capex
$60.8M
$44.1M
FCF MarginFCF / Revenue
20.8%
16.2%
Capex IntensityCapex / Revenue
1.8%
1.2%
Cash ConversionOCF / Net Profit
1.70×
TTM Free Cash FlowTrailing 4 quarters
$172.1M
$145.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLBT
CLBT
KAI
KAI
Q3 25
$66.2M
$47.3M
Q2 25
$53.5M
$40.5M
Q1 25
$10.0M
$22.8M
Q4 24
$51.9M
Q3 24
$58.2M
$52.5M
Q2 24
$24.6M
$28.1M
Q1 24
$12.5M
$22.8M
Q4 23
$59.2M
Free Cash Flow
CLBT
CLBT
KAI
KAI
Q3 25
$60.8M
$44.1M
Q2 25
$47.5M
$36.5M
Q1 25
$8.5M
$19.0M
Q4 24
$46.3M
Q3 24
$55.3M
$48.3M
Q2 24
$21.0M
$23.1M
Q1 24
$11.4M
$16.6M
Q4 23
$49.5M
FCF Margin
CLBT
CLBT
KAI
KAI
Q3 25
20.8%
16.2%
Q2 25
21.5%
14.3%
Q1 25
9.5%
7.9%
Q4 24
17.9%
Q3 24
23.8%
17.8%
Q2 24
11.3%
8.4%
Q1 24
16.0%
6.7%
Q4 23
20.7%
Capex Intensity
CLBT
CLBT
KAI
KAI
Q3 25
1.8%
1.2%
Q2 25
2.7%
1.6%
Q1 25
1.7%
1.6%
Q4 24
2.2%
Q3 24
1.3%
1.5%
Q2 24
1.9%
1.8%
Q1 24
1.5%
2.5%
Q4 23
4.1%
Cash Conversion
CLBT
CLBT
KAI
KAI
Q3 25
1.70×
Q2 25
1.45×
1.55×
Q1 25
0.95×
Q4 24
2.16×
Q3 24
1.66×
Q2 24
0.90×
Q1 24
0.92×
Q4 23
2.16×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLBT
CLBT

Subscription services$197.2M67%
Term-license$60.8M21%
Professional services$23.2M8%
Other non-recurring$11.0M4%

KAI
KAI

Flow Control$94.8M35%
Capital$83.2M31%
Material Handling Systems$70.3M26%
Transferred Over Time$17.1M6%
Other$6.1M2%

Related Comparisons